Cough, cold and allergy (hay fever) remedies will see a sharp deceleration in value sales growth during 2020 due to the impact of COVID-19. As a result of the country’s long and cold winters, consumer demand for cough, cold and allergy (hay fever) remedies tends to be very strong in Lithuania, and this was particularly the case during 2019, when the flu season was unusually severe.
Current value sales growth of antihistamines/allergy remedies (systemic) will suffer an even sharper slowdown than those of cough remedies during 2020. Sales of these products are tied to seasonal allergies and usually begin to pick up in February in preparation for the beginning of spring, but in 2020, this seasonal effect was much weaker than usual.
Ratiopharm Gruppe (Teva Pharmaceutical Industries Ltd), Sandoz Pharmaceuticals dd, GSK Consumer Healthcare and Bionorica GmbH will remain the leading players in cough, cold and allergy (hay fever) remedies during 2020. All of these players benefit from economies of scale in research and development, manufacturing and marketing.
The number of people affected by such allergies as dermatitis, rhinitis, asthma and particularly hay fever is on the rise in Lithuania, especially among children. Consumers usually seek out products containing such ingredients as cetirizine and loratadine to tackle the symptoms produced by these allergies.
Increasingly hectic lifestyles and a growing desire for convenience will continue to drive current value sales growth for combination products, such as Coldrex, Brontex, Flavamed and ACC, and nasal sprays over the course of the forecast period. While consumer interest in herbal/traditional remedies for cold and flu symptoms is on the rise, they continue to desire efficacy and speed above all else, and combination products are still perceived by many as the best solution in this regard.
While chemists/pharmacists continue to dominate distribution, e-commerce is a small, but emerging, channel, in cough, cold and allergy (hay fever) remedies. Even before the onset of COVID-19, it accounted for a larger proportion of value sales than grocery retailers, and the pandemic has given it a further boost: With consumers forced to spend more time at home, they are turning to internet retail in growing numbers.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Lithuania with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Lithuania, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page